Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-05-14

Clinical Trial Update: Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma [Phase 2]

View source ↗

Summary

A Phase 2 intra-arterial chemotherapy trial for advanced intraocular retinoblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Retinoblastoma, Eye Cancer | Phase 2 | Status: WITHDRAWN